Publicaciones en las que colabora con FRANCISCO JAVIER ALVAREZ GONZALEZ (21)

2023

  1. Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study

    Environmental Research, Vol. 229

2022

  1. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points

    Frontiers in Medicine, Vol. 9

  2. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

2021

  1. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials

    Frontiers in Medicine, Vol. 8

  2. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

  3. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  4. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  5. Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles

    Journal of Clinical Medicine, Vol. 10, Núm. 22

2019

  1. Nosocomial vs. Community-acquired infective endocarditis in spain: Location, trends, clinical presentation, etiology, and survival in the 21st century

    Journal of Clinical Medicine, Vol. 8, Núm. 10

2011

  1. El polimorfismo R753Q del toll-like receptor 2 se asocia a un aumento en el riesgo de sufrir endocarditis infecciosa

    Revista Espanola de Cardiologia, Vol. 64, Núm. 11, pp. 1056-1059

2000

  1. The use of antihypertensive therapy in Spain (1986-1994)

    American Journal of Hypertension, Vol. 13, Núm. 6 II SUPPL., pp. 607-610

1987

  1. Farmacoterapia del aparato digestivo

    Madrid : Laboratorios Delagrange, 1987

1985

  1. Effect of loperamide and non-steroid anti-inflammatory drugs on water, glucose and electrolyte transport in the small intestine of the rat in vivo

    IRCS Medical Science, Vol. 13, Núm. 3, pp. 247

  2. Effect of trazodone on oxidative metabolism of rat brain. In vitro

    Revista Espanola de Fisiologia, Vol. 41, Núm. 2, pp. 201-206

1984

  1. EFECTO DE LA HEMINEURINA SOBRE EL METABOLISMO OXIDATIVO DE DIVERSOS TEJIDOS DE RATA IN VITRO

    Archivos de Neurobiologia, Vol. 47, Núm. 1, pp. 37-44

  2. Effect of etomidate on oxidative metabolism of rat brain in vitro

    IRCS Medical Science, Vol. 12, Núm. 12, pp. 1155

1983

  1. ANALISIS COMPARATIVO DE TRAZODONE E IMIPRAMINA FRENTE A ACETILCOLINA Y ESTIMULO ELECTRICO EN EL ILEON AISLADO DE COBAYO

    Archivos de Farmacologia y Toxicologia, Vol. 9, Núm. 3, pp. 263-268

  2. EFECTO DEL SULFATO DE ETOMIDATO SOBRE LA ACTIVIDAD OXIDATIVA DE HIGADO, RINON Y CORAZON DE RATA 'IN VITRO'

    Archivos de Farmacologia y Toxicologia, Vol. 9, Núm. 3, pp. 269-274

1982

  1. EFECTO DEL CLORHIDRATO DE TRAZODONE SOBRE EL METABOLISMO OXIDATIVO Y ACTIVIDAD ATPASA DE CEREBRO DE RATA IN VITRO

    Archivos de Farmacologia y Toxicologia, Vol. 8, Núm. 3, pp. 147-150

  2. EFECTO DEL ETOMIDATO SOBRE EL METABOLISMO OXIDATIVO Y ACTIVIDAD ATPASE DE CEREBRO DE RATA IN VITRO

    Archivos de Farmacologia y Toxicologia, Vol. 8, Núm. 3, pp. 237-238